These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12893219)

  • 1. Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus.
    Montagut C; Mármol M; Rey V; Ordi J; Pahissa J; Rovirosa A; Gascón P; Mellado B
    Gynecol Oncol; 2003 Aug; 90(2):458-61. PubMed ID: 12893219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesonephric adenocarcinoma in the uterine corpus: A case report and review of the literature.
    Tang X; Li L; He Y
    Indian J Pathol Microbiol; 2021; 64(4):806-809. PubMed ID: 34673610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.
    Yoo HJ; Lim MC; Lim S; Park JY; Kang S; Park SY; Seo SS
    Arch Gynecol Obstet; 2012 Dec; 286(6):1529-35. PubMed ID: 22825691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.
    Hoskins PJ; Le N; Ellard S; Lee U; Martin LA; Swenerton KD; Tinker AV;
    Gynecol Oncol; 2008 Jan; 108(1):58-62. PubMed ID: 17935761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study.
    Aghajanian C; Sill MW; Secord AA; Powell MA; Steinhoff M
    Gynecol Oncol; 2012 Sep; 126(3):424-7. PubMed ID: 22634397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma.
    Lacour RA; Euscher E; Atkinson EN; Sun CC; Ramirez PT; Coleman RL; Brown J; Gano JB; Burke TW; Ramondetta LM
    Int J Gynecol Cancer; 2011 Apr; 21(3):517-22. PubMed ID: 21436700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
    Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
    Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin.
    Hirashima Y; Kobayashi H; Nishiguchi T; Miura K; Kanayama N
    Anticancer Drugs; 2001 Aug; 12(7):627-30. PubMed ID: 11487720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesonephric adenocarcinomas in female genital tract: A case series.
    Xie C; Chen Q; Shen Y
    Medicine (Baltimore); 2021 Sep; 100(35):e27174. PubMed ID: 34477176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Adenocarcinoma, HPV-independent, Mesonephric Type with Significant Response to Neoadjuvant Chemotherapy].
    Kuratsune K; Ueda T; Tajiri R; Tohyama A; Hoshino K; Harada H; Kurita T; Kubo C; Komatsu K; Shiba E; Matsuura Y; Yoshino K
    J UOEH; 2024; 46(1):45-51. PubMed ID: 38479874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal?
    Markman M
    J Cancer Res Clin Oncol; 2004 Nov; 130(11):645-8. PubMed ID: 15300428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma.
    Michener CM; Peterson G; Kulp B; Webster KD; Markman M
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):581-4. PubMed ID: 15959825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus.
    Toyoshima M; Akahira J; Matsunaga G; Niikura H; Ito K; Yaegashi N; Tase T
    Gynecol Oncol; 2004 Sep; 94(3):774-8. PubMed ID: 15350372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report.
    Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Tangtiang K; Piyawang W; Bhamarapravatana K
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S121-5. PubMed ID: 26387399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
    Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage III adenocarcinoma of esophagogastric junction].
    Ji Y; Peng T; Wang G; Zhang Y; Cao M; Gao Q; Li S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1019-1024. PubMed ID: 30269322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.
    Pectasides D; Pectasides E; Papaxoinis G; Xiros N; Sykiotis C; Papachristodoulou A; Tountas N; Panayiotides J; Economopoulos T
    Gynecol Oncol; 2008 Sep; 110(3):299-303. PubMed ID: 18602677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):225-7. PubMed ID: 17301532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
    Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
    Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung adenocarcinoma with multiple pulmonary metastases completely responsive to combination chemotherapy with carboplatin and weekly paclitaxel--a case report].
    Ishida T; Tomiyasu M; Kohso H; Iwanami T; Ikegami T; Okazaki J; Emi Y; Kido A; Ezaki T
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1313-6. PubMed ID: 14518412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.